Constitutional Issues in the Use of Pharmacogenomic Variations Associated with Race
Summary
Medical evidence now indicates that some racial and ethnic groups react differently to some drugs and therapies than other groups. Developing effective therapies for all racial and ethnic groups may mean taking their race or ethnicity into account in screening for disease or in prescribing therapy. When a close medical connection can be shown, the use of racial and ethnic categories in research and clinical care may be constitutional as a way of ensuring good health care for those groups.